본문 바로가기

Investment Agreement Signed with Ajinomoto Genexine for Songdo International City
  • Date Created : 2013-02-13
  • Number of Views : 10
(130213)아지노모도 제넥신 투자 협약 체결(01)
(130213)아지노모도 제넥신 투자 협약 체결(02)
(130213)아지노모도 제넥신 투자 협약 체결(01)
(130213)아지노모도 제넥신 투자 협약 체결(02)

On Wednesday, January 30, 2013, IFEZ signed an investment agreement with Ajinomoto Genexine for investment in Songdo International City. Ajinomoto Genexine is a joint venture established by Japan’s Ajinomoto and Korea’s biotech venture Genexine, and it promoted a project to produce cell culture media in Songdo International City. The company later invested KRW 35.7 billion (approximately USD 32.9 million) to build Korea’s first cell culture media production system and moved forward with the localization of raw materials for the bio industry.